# Omega 3 Skin Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/omega-3-skin-randomized-trial-evidence-review
Category: evidence-review
Summary: Omega 3 Skin Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systemati
Last reviewed: 2026-07-30
Reviewed by: Migaku Evidence Review
# Omega 3 Skin Randomized Trial: What the Evidence Says

## Quick Answer

Omega 3 Skin Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effectiveness of Eicosapentaenoic and Docosahexaenoic Acid Supplementation for Reducing Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials | systematic review | 1 | 2026-01-20 | 10.3390/ph19010181 |
| The State of Prevention of Atopic Dermatitis: An Updated Review | narrative review | 3 | 2026-02-22 | 10.1111/pde.70157 |

## What The Sources Report

- Uremic pruritus significantly diminishes patients' quality of life and is associated with sleep disruption and emotional distress. [Chou Chia-An (2026); evidence level 1]
- Current evidence suggests that uremic pruritus arises from a multifactorial pathophysiology involving systemic inflammation, xerosis, and dysregulation of the endogenous opioid system. [Chou Chia-An (2026); evidence level 1]
- The interventions described aim to maintain the integrity of the skin barrier, promote a balanced microbiome, and prevent inflammation associated with AD. [Kiszluk Alexandra (2026); evidence level 3]
- - Preventing atopic dermatitis and allergies in children (PreventADALL) Moisturizer at least four times weekly from the second week through the eighth month of life and early introduction of peanut butter, eggs, milk, and wheat 2397 7.4% risk reduction of AD at 3 years of age (95% confidence interval −12.1 to −2.7) 15 Yuguchi et al. [Kiszluk Alexandra (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For omega 3 skin randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Chou Chia-An (2026). Effectiveness of Eicosapentaenoic and Docosahexaenoic Acid Supplementation for Reducing Uremic Pruritus: A Meta-Analysis of Randomized Controlled Trials. DOI: 10.3390/ph19010181. PMCID: PMC12844951. PMID: 41599777. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12844951/
- Kiszluk Alexandra (2026). The State of Prevention of Atopic Dermatitis: An Updated Review. DOI: 10.1111/pde.70157. PMCID: PMC13206429. PMID: 41723876. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13206429/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.